Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? Or are you new to this field?
HIV.gov curates learning opportunities for you, and the people you serve and collaborate with.
Stay up to date with the webinars, Twitter chats, conferences and more in this section.
01-22-2021@US_FDA has approved Cabenuva (cabotegravir and rilpivirine), the first injectable, complete treatment regimen for people with #HIV that is administered once a.…